Physician profile
Cyrus Ma
NPI 1669133369
$5,525.82
in general payments reported to CMS, 2019-2025
19 companies · $2,260 in 2025
The $2,260 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $320 · 2024: $2,947 · 2025: $2,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,525.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $823.60 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $786.87 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $544.03 | 2023-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $441.08 | 2024-2025 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $408.61 | 2023-2025 | Ingrezza |
| Supernus Pharmaceuticals, INC. | $372.04 | 2024-2025 | Qelbree |
| Axsome Therapeutics, INC. | $337.35 | 2023-2025 | Auvelity |
| Corium, LLC | $323.84 | 2023-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $293.24 | 2023-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $251.95 | 2025 | Spravato |
| Tris Pharma INC | $243.78 | 2023-2025 | Dyanavel Xr |
| Alkermes, INC. | $217.11 | 2023-2025 | Aristada, Lybalvi |
| Ironshore Pharmaceuticals INC. | $143.55 | 2023-2024 | Jornay Pm |
| Lundbeck LLC | $113.59 | 2024-2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $63.11 | 2025 | Jornay Pm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $53.93 | 2024-2025 | Adzenys Xr-Odt |
| Biogen, INC. | $44.30 | 2025 | Zurzuvae |
| Livanova USA, INC. | $38.01 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| Tms Neurohealth Centers INC. | $25.83 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyrus Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.